Joshua H. Bilenker

Filings by Joshua H. Bilenker span 2 companies, the busiest being Loxo Oncology, Inc. and Sana Biotechnology, Inc. Between 3 October 2001 and 3 February 2021, the trades on record add up to 168 filings.

On the open market, the record shows 1 purchase worth €415k and 135 sales worth €31.8M. On balance, insiders were net sellers of €31.4M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 29 option exercises. Since January 2023: 1 purchase and no sales on the market.

Most recently, on 17 February 2023, the filings show an open-market purchase worth €415k in Sana Biotechnology, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.